Format

Send to

Choose Destination
ACS Nano. 2016 Jan 26;10(1):1699-710. doi: 10.1021/acsnano.5b07939. Epub 2016 Jan 12.

A Digital-Analog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples.

Author information

1
Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne , Lausanne 1015, Switzerland.

Abstract

Microfluidic diagnostic devices have the potential to transform the practice of medicine. We engineered a multiplexed digital-analog microfluidic platform for the rapid and highly sensitive detection of 3-4 biomarkers in quadruplicate in 16 independent and isolated microfluidic unit cells requiring only a single 5 μL sample. We comprehensively characterized the platform by performing single enzyme and digital immunoassays, achieving single molecule detection and measured as low as ∼10 fM (330 fg/mL) GFP in buffer and ∼12 fM GFP in human serum. We applied our integrated digital detection mechanism to multiplexed detection of 1pM anti-Ebola IgG in human serum and were able to differentiate three common Ebola strains. To ascertain that the device can be applied in environments beyond clinical point-of-care settings, we developed a low-cost, portable hardware system to control and read out the microfluidic device and detected anti-Ebola IgG in ultralow volume whole blood samples to levels of 100 pM in a multiplexed assay format.

KEYWORDS:

ELISA; diagnostics; digital immunoassay; microarrays; microfluidics; point-of-care; single-enzyme analysis

PMID:
26741022
DOI:
10.1021/acsnano.5b07939

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center